{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:29:32Z","timestamp":1792441772818,"version":"4.5.0"},"reference-count":38,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2021,6,3]]},"DOI":"10.1080\/03007995.2021.1904861","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T09:22:40Z","timestamp":1616059360000},"page":"1021-1030","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Value-based decision-making for orphan drugs with multiple criteria decision analysis: burosumab for the treatment of X-linked hypophosphatemia"],"prefix":"10.1080","volume":"37","author":[{"given":"Bj\u00f6rn","family":"Vandewalle","sequence":"first","affiliation":[{"name":"Exigo Consultores, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Amorim","sequence":"additional","affiliation":[{"name":"Exigo Consultores, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo","family":"Ramos","sequence":"additional","affiliation":[{"name":"Exigo Consultores, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Exigo Consultores, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Alves","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o Nacional de Displasias \u00d3sseas, \u00c9vora, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Telma","family":"Francisco","sequence":"additional","affiliation":[{"name":"Centro Hospitalar Universit\u00e1rio Lisboa Central, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Pinto","sequence":"additional","affiliation":[{"name":"Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"Sousa","sequence":"additional","affiliation":[{"name":"Centro Hospitalar e Universit\u00e1rio de Coimbra, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-017-9408-1"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1007\/s00590-014-1496-y"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.340"},{"key":"CIT0004","unstructured":"Ruppe MD. X-linked hypophosphatemia, Gene Reviews. Seattle (WA): University of Washington; 2017."},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650070602"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(87)80245-7"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1136\/adc.65.10.1125"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1007\/BF00860736"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112263252604"},{"key":"CIT0010","unstructured":"The National Institute for Health and Care Excellence (NICE). Highly specialised technologies guidance - Burosumab for treating X-linked hypophosphataemia in children and young people. [cited August 11, 2019]. Available from: www.nice.org.uk\/guidance\/hst8."},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13763"},{"key":"CIT0012","unstructured":"Kyowa Kirin. Crysvita (burosumab), Summary of product characteristics. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/crysvita-epar-product-information_en.pdf"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1078-5"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00487"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-017-0871-0"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462316000416"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-012-0001-x"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00287"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-014-0135-0"},{"key":"CIT0020","unstructured":"Pavan M, Todeschini R. Multicriteria decision-making methods. In: Comprehensive chemometrics [Recurso electr\u00f3nico]: chemical and biochemical data analysis. Vol. 1. Elsevier; 2020."},{"key":"CIT0021","unstructured":"Santos M, Oliveira A, Vandewalle B, et al. A multi-criteria decision analysis assessment of teduglutide in the treatment of adults with short bowel syndrome and intestinal failure in Portugal. In: XXXVIII Congresso da Sociedade Portuguesa de Cirurgia. Lisbon; 2018."},{"key":"CIT0022","unstructured":"Orme B. Getting started with conjoint analysis: strategies for product design and pricing research. Vol. 3. Manhattan Beach (CA): Research Publishers; 2014."},{"key":"CIT0023","unstructured":"Johnson RM. Adaptive Conjoint Analysis. in Sawtooth Software Conference on Perceptual Mapping, Conjoint Analysis, and Computer Interviewing. 1987."},{"key":"CIT0024","unstructured":"The ACA\/Web v6.0 Technical Paper. Technical Paper Series 2007;Available from: https:\/\/www.sawtoothsoftware.com\/support\/technical-papers\/aca-related-papers\/aca-technical-paper-2007."},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-005-2077-4"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2017.06.024"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0555-3"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.10.002"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2016.00214"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1121-6"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0340-5"},{"key":"CIT0032","unstructured":"Working Group on Mechanism of Coordinated Access to Orphan Medicinal Products (MoCA-OMP). Transparent Value Framework. 2014. [cited August 11, 2019]. Available from: http:\/\/download2.eurordis.org.s3.amazonaws.com\/moca\/history\/WG%20MoCA-OMP%20Transparent%20Value%20Framework.pdf."},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0601-9"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.02.019"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.12.016"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1002\/mcda.1544"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7547-12-22"},{"key":"CIT0038","unstructured":"National Institute for Health and Care Excellence (NICE). Final Evaluation Document: Burosumab for treating X-linked hypophosphataemia in children and young people. 2018. [cited August 11, 2019]; Available from: https:\/\/www.nice.org.uk\/guidance\/hst8\/evidence."}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2021.1904861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T14:33:28Z","timestamp":1622471608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2021.1904861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,3]]}},"alternative-id":["10.1080\/03007995.2021.1904861"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2021.1904861","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-11-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}